Ginkgo Biloba
Ginkgo has seizure case reports, and clozapine has a dose-related seizure boxed warning.
Recommendation: Avoid ginkgo in patients taking clozapine, especially at higher clozapine doses or with any seizure risk factor.
Prescription ·Strong evidence ·Reviewed May 2026
Clozapine is an atypical antipsychotic reserved for treatment-resistant schizophrenia and for reducing recurrent suicidal behavior in schizophrenia or schizoaffective disorder. It has unique efficacy but multiple boxed warnings, including severe neutropenia, orthostatic hypotension with bradycardia and syncope, seizures, myocarditis or cardiomyopathy, and increased mortality in elderly patients with dementia-related psychosis. ANC monitoring remains required by prescribing information even though FDA removed the Clozapine REMS program effective June 13, 2025.
The bottom line
Evidence rating strong. Most-documented uses: treatment-resistant schizophrenia after inadequate response to standard antipsychotics, reduction in recurrent suicidal behavior in schizophrenia or schizoaffective disorder, may reduce aggression or severe psychotic symptoms in selected refractory cases. 3 sources indexed (1988–2026), with 4 interaction records on file.
Core mechanism
Clozapine has complex receptor pharmacology, including dopamine D2/D4, serotonin 5-HT2A/2C, muscarinic, histamine H1, and alpha-adrenergic effects. Its antipsychotic efficacy in treatment resistance is not explained solely by D2 blockade and may involve broader dopaminergic, serotonergic, glutamatergic, and cholinergic modulation. CYP1A2 is the main metabolic pathway, with contributions from CYP3A4 and CYP2D6; inflammation, smoking changes, and inhibitors can substantially alter exposure.1,2
May be taken with or without food. Restarting after an interruption requires retitration to reduce severe hypotension, bradycardia, and syncope risk.
Ginkgo has seizure case reports, and clozapine has a dose-related seizure boxed warning.
Recommendation: Avoid ginkgo in patients taking clozapine, especially at higher clozapine doses or with any seizure risk factor.
Melatonin can add to clozapine-related sedation, dizziness, and impaired coordination.
Recommendation: Use cautiously and monitor next-day sedation, falls, and confusion.
St. John's Wort induces drug-metabolizing enzymes and transporters and may lower exposure to some antipsychotics or destabilize psychiatric treatment.
Recommendation: Avoid St. John's Wort unless the psychiatric prescriber explicitly approves and clozapine response is monitored closely.
Ashwagandha can be sedating in some patients and may add to clozapine-related somnolence or orthostatic symptoms.
Recommendation: Avoid during clozapine initiation and use cautiously if stable; monitor for sedation and falls.
Numbered references. Citations throughout the page link here.
Pivotal trial established clozapine efficacy in treatment-resistant schizophrenia compared with chlorpromazine plus benztropine.
Current labeling describes boxed warnings, ANC thresholds, slow titration, restart instructions, and serious constipation risk.
FDA eliminated REMS requirements effective June 13, 2025 while preserving ANC monitoring recommendations in labeling.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.